Generic Injectable Market Growth & Forecast 2025-2035

Future Market Insights

Generic Injectable Market

Key Insight

The generic injectable market was valued at USD 135.4 billion in 2025 and is forecast to register an 11.5% CAGR between 2025 and 2035. In 2025, monoclonal antibodies hold ~38.7% of product demand, small molecules represent 62.8% of molecule type sales and tier 1 companies account for ~58.0% within the players segment.

August 29, 2025

Anurag Sharma

640 Pages

Cite this Report

Generic Injectable Market

https://www.futuremarketinsights.com/reports/generic-injectable-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

BlackRock
Aurobindo Pharma
Baxter International
Cipla Ltd
Dr. Reddy’s Laboratories
Fresenius Kabi AG
Merck KGaA
Mylan N.A
Novartis
The Vanguard Group
Samsung Biologics
L'Oréal
Sun Pharmaceutical Industries Ltd
Teva Pharmaceuticals

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Generic Injectable Market

Key Players

Similar Industry Reports